CX 2021 Programme

If you have any questions concerning the scientific programme, please contact us at [email protected]

All times are London time BST (British Summer Time), which is GMT+1. The organisers reserve the right to alter timings if necessary.


Search for words

Live stream 1
Live stream 2
CX On Demand
Satellite Symposia
DEEP VENOUS Controversies - Wednesday, 21st April
Venue:   Livestream 2
Time: 14:00 - 19:30
Deep venous controversies
Time: 14:00 - 15:00
Moderators:   Stephen Black, London, United Kingdom
Manj Gohel, Cambridge, United Kingdom
14:00 - 14:05
Defining ‘inappropriate’ stenting for non-thrombotic iliac vein disease
Speaker:   Steve Elias, Englewood, United States
14:05 - 14:10
Audience participation and discussion
14:10 - 14:20
CX Debate: Pre-procedure anatomy is enough to predict outcomes after deep venous stenting

For the motion
14:10 - 14:15
Houman Jalaie, Aachen, Germany

Against the motion
14:15 - 14:20
William Marston, Chapel Hill, United States

14:20 - 14:30
Audience participation, discussion and polling
14:30 - 14:35
Key patient characteristics that determine outcomes after deep venous stenting
Speaker:   Erin Murphy, Charlotte, United States
14:35 - 14:40
Audience participation and discussion
14:40 - 14:45
Edited case: Lessons from early and late deep vein stent thrombosis
Speaker:   Gerard O’Sullivan, Galway, Ireland
14:45 - 14:50
Audience participation and discussion
14:50 - 14:55
Podium 1st: The importance of complete early thrombus removal - CLEAR DVT study
Speaker:   Mitchell Silver, Columbus, United States
14:55 - 15:00
Audience participation and discussion
 
Networking break
Time: 15:00 - 15:30
Satellite Symposium: Redefining vascular treatment strategy for AVF and AVG: A deep dive into sirolimus-coated balloon
Time: 15:00 - 15:30
Chairing:   Konstantinos Katsanos, Patras, Greece
Moderator:   Tjun Tang, Singapore, Singapore
15:00 - 15:06
Treatment of AVF stenosis with DCBs: Advantages of sirolimus over paclitaxel
Speaker:   Aloke Finn, Gaithersburg, United States
15:06 - 15:13
MATILDA trial one-year outcomes
Speaker:   TBA
15:13 - 15:20
Sirolimus-coated balloon use at the graft-vein junction in thrombosed AVGs - one-year outcome data
Speaker:   Chieh Suai Tan, Singapore, Singapore
15:20 - 15:30
Audience participation, discussion and conclusions
 
Deep venous controversies (continued)
Time: 15:30 - 16:30
Moderators:   Armando Mansilha, Porto, Portugal
Manj Gohel, Cambridge, United Kingdom
15:30 - 15:35
Robotic caval surgery for renal tumour and the Nutcracker Syndrome
Speaker:   Samuel Money, Phoenix, United States
15:35 - 15:40
Audience participation and discussion
15:40 - 15:45
Clinical and economic burden of venous leg ulcers with deep venous obstruction
Speaker:   Raghu Kolluri, Columbus, United States
15:45 - 15:50
Audience participation and discussion
15:50 - 15:55
Determining the adequacy of inflow for patients with post-thrombotic venous outflow obstruction
Speaker:   Paul Gagne, Darien, United States
15:55 - 16:00
Audience participation and discussion
16:00 - 16:05
Areas of ongoing controversy in deep venous management: Findings from a Delphi consensus
Speaker:   Rick de Graaf, Friedrichshafen, Germany
16:05 - 16:10
Audience participation and discussion
16:10 - 16:15
Anticoagulation strategies after deep venous stenting interventions
Speaker:   Stephen Black, London, United Kingdom
16:15 - 16:20
Audience participation and discussion
16:20 - 16:25
Hip biomechanics and venous stent durability testing
Speaker:   Kush Desai, Chicago, United States
16:25 - 16:30
Audience participation and discussion
 
Networking break
Time: 16:30 - 17:00
Satellite Symposium: Modern treatments for DVT and PTS: Prep, dilate, treat
Time: 16:30 - 17:00
Moderator:   Gerard O’Sullivan, Galway, Ireland
16:30 - 16:35
The evidence for treatment - why you should intervene on acute DVT
Speaker:   Stephen Black, London, United Kingdom
16:35 - 16:40
Anticoagulation management - paying attention to detail
Speaker:   Karen Breen, London, United Kingdom
16:40 - 16:48
Mechanical aspiration thrombectomy system in iliofemoral deep vein thrombosis: Arnsberg registry
Speaker:   Michael Lichtenberg, Arnsberg, Germany
16:48 - 16:56
Recorded case - Deep venous obstruction and saphenous reflux
Speaker:   Houman Jalaie, Aachen, Germany
16:56 - 17:00
Panel discussion
 
One-stop diagnosis - the hurting leg: Pathways at speed
Time: 17:00 - 17:30
Moderators:   Manj Gohel, Cambridge, United Kingdom
Armando Mansilha, Porto, Portugal
17:00 - 17:05
The importance of one-stop rapid assessment for hurting legs
Speaker:   Tristan Lane, London, United Kingdom
17:05 - 17:10
Audience participation and discussion
17:10 - 17:15
The optimal diagnostic strategy for the hurting leg
Speaker:   Prakash Saha, London, United Kingdom
17:15 - 17:20
Audience participation and discussion
17:20 - 17:25
Speed of access to prevent complications from venous thrombosis
Speaker:   Gerard O’Sullivan, Galway, Ireland
17:25 - 17:30
Audience participation and discussion
 
Venous wound controversies
Time: 17:30 - 18:00
Moderators:   Armando Mansilha, Porto, Portugal
Stephen Black, London, United Kingdom
17:30 - 17:40
CX Debate: For patients with C6 disease, the iliac venous outflow should be routinely and specifically imaged

For the motion
17:30 - 17:35
Antonios Gasparis, Stony Brook, United States

Against the motion
17:35 - 17:40
Alun Davies, London, United Kingdom

17:40 - 17:50
Audience participation, discussion and polling
17:50 - 17:55
The influence of endovenous modality and technique on clinical outcomes in C6 patients
Speaker:   Manj Gohel, Cambridge, United Kingdom
17:55 - 18:00
Audience participation and discussion
 
Networking break
Time: 18:00 - 18:30
Satellite Symposium: Mechanical thrombectomy for the treatment of chronic illiofemoral DVT - a sub-analysis of the CLOUT registry and first-hand experience
Time: 18:00 - 18:30
Moderator:   Thomas Tu, Irvine, United States
18:00 - 18:05
Introduction
Moderator:   Thomas Tu, Irvine, United States
18:05 - 18:25
Presentation of sub-analysis data and case examples
Speaker:   Steven Abramowitz, Washington, United States
18:25 - 18:30
Audience participation and discussion
 
Miscellaneous venous controversies
Time: 18:30 - 19:30
Moderators:   Stephen Black, London, United Kingdom
Armando Mansilha, Porto, Portugal
18:30 - 18:35
Removing embedded IVC filters: Just because you can, does it mean you should?
Speaker:   Kush Desai, Chicago, United States
18:35 - 18:40
Audience participation and discussion
18:40 - 18:45
Indications, techniques and evidence for upper extremity deep venous stenting
Speaker:   Steven Dubenec, Sydney, Australia
18:45 - 18:50
Audience participation and discussion
18:50 - 18:55
Principles for prioritisation of venous interventions
Speaker:   Sergio Gianesini, Ferrara, Italy
18:55 - 19:00
Audience participation and discussion
Roundtable
Time: 19:00 - 19:30
19:00 - 19:05
VIVO study 12-month results: Analysis of outcomes in patients with stent extension below the inguinal ligament
Speaker:   Anthony Comerota, Alexandria, United States
19:05 - 19:10
VTE risk assessment and thromboprophylaxis in the COVID-19 era
Speaker:   Joseph Caprini, Northfield, United States
The future of VTE research
Speaker:   Stephen Black, London, United Kingdom
19:15 - 19:30
Audience participation and discussion